Breast Cancer Research Review, Issue 24

In this issue:

Internet-based CBT relieves post-chemo severe fatigue
Endoxifen in endocrine-refractory metastatic disease
Comparing trastuzumab-based regimens in older women
Bisphosphonates do not reduce breast cancer risk
CGA testing of older women with early disease
Characteristics of male breast cancer
MAF status predicts benefit from adjuvant zoledronic acid
Tumour genomic profiling in metastatic disease: few benefit
Intense dose-dense adjuvant chemo in high-risk disease
Palbociclib + letrozole in HR+ advanced disease: not cost-effective
 

Please login below to download this issue (PDF)

Subscribe